322 related articles for article (PubMed ID: 23799774)
1. scAAV9 intracisternal delivery results in efficient gene transfer to the central nervous system of a feline model of motor neuron disease.
Bucher T; Colle MA; Wakeling E; Dubreil L; Fyfe J; Briot-Nivard D; Maquigneau M; Raoul S; Cherel Y; Astord S; Duque S; Marais T; Voit T; Moullier P; Barkats M; Joussemet B
Hum Gene Ther; 2013 Jul; 24(7):670-82. PubMed ID: 23799774
[TBL] [Abstract][Full Text] [Related]
2. Motor neuron transduction after intracisternal delivery of AAV9 in a cynomolgus macaque.
Bell P; Hinderer C; Louboutin JP; Yu H; Grant R; Bote E; Wilson JM
Hum Gene Ther Methods; 2015 Apr; 26(2):43-4. PubMed ID: 25885277
[TBL] [Abstract][Full Text] [Related]
3. A Safe and Reliable Technique for CNS Delivery of AAV Vectors in the Cisterna Magna.
Taghian T; Marosfoi MG; Puri AS; Cataltepe OI; King RM; Diffie EB; Maguire AS; Martin DR; Fernau D; Batista AR; Kuchel T; Christou C; Perumal R; Chandra S; Gamlin PD; Bertrand SG; Flotte TR; McKenna-Yasek D; Tai PWL; Aronin N; Gounis MJ; Sena-Esteves M; Gray-Edwards HL
Mol Ther; 2020 Feb; 28(2):411-421. PubMed ID: 31813800
[TBL] [Abstract][Full Text] [Related]
4. Intracerebroventricular injection of adeno-associated virus 6 and 9 vectors for cell type-specific transgene expression in the spinal cord.
Dirren E; Towne CL; Setola V; Redmond DE; Schneider BL; Aebischer P
Hum Gene Ther; 2014 Feb; 25(2):109-20. PubMed ID: 24191919
[TBL] [Abstract][Full Text] [Related]
5. Efficient CNS targeting in adult mice by intrathecal infusion of single-stranded AAV9-GFP for gene therapy of neurological disorders.
Bey K; Ciron C; Dubreil L; Deniaud J; Ledevin M; Cristini J; Blouin V; Aubourg P; Colle MA
Gene Ther; 2017 May; 24(5):325-332. PubMed ID: 28425480
[TBL] [Abstract][Full Text] [Related]
6. Comparison of adeno-associated viral vector serotypes for spinal cord and motor neuron gene delivery.
Snyder BR; Gray SJ; Quach ET; Huang JW; Leung CH; Samulski RJ; Boulis NM; Federici T
Hum Gene Ther; 2011 Sep; 22(9):1129-35. PubMed ID: 21443428
[TBL] [Abstract][Full Text] [Related]
7. Transduction efficiency of neurons and glial cells by AAV-1, -5, -9, -rh10 and -hu11 serotypes in rat spinal cord following contusion injury.
Petrosyan HA; Alessi V; Singh V; Hunanyan AS; Levine JM; Arvanian VL
Gene Ther; 2014 Dec; 21(12):991-1000. PubMed ID: 25119378
[TBL] [Abstract][Full Text] [Related]
8. Intrathecal shRNA-AAV9 inhibits target protein expression in the spinal cord and dorsal root ganglia of adult mice.
Hirai T; Enomoto M; Machida A; Yamamoto M; Kuwahara H; Tajiri M; Hirai Y; Sotome S; Mizusawa H; Shinomiya K; Okawa A; Yokota T
Hum Gene Ther Methods; 2012 Apr; 23(2):119-27. PubMed ID: 22583159
[TBL] [Abstract][Full Text] [Related]
9. [Experimental approach to the gene therapy of motor neuron disease with the use of genes hypoxia-inducible factors].
Ismailov ShM; Barykova IuA; Shmarov MM; Tarantul VZ; Barskov IV; Kucherianu VG; Brylev LV; Logunov DIu; Tutykhina IL; Bocharov EV; Zakharova MN; Naroditskiĭ BS; Illarioshkin SN
Genetika; 2014 May; 50(5):591-601. PubMed ID: 25715475
[TBL] [Abstract][Full Text] [Related]
10. Development of gene therapy for treatment of age-related macular degeneration.
Askou AL
Acta Ophthalmol; 2014 Jul; 92 Thesis3():1-38. PubMed ID: 24953666
[TBL] [Abstract][Full Text] [Related]
11. Transduction Profile of the Marmoset Central Nervous System Using Adeno-Associated Virus Serotype 9 Vectors.
Matsuzaki Y; Konno A; Mukai R; Honda F; Hirato M; Yoshimoto Y; Hirai H
Mol Neurobiol; 2017 Apr; 54(3):1745-1758. PubMed ID: 26884266
[TBL] [Abstract][Full Text] [Related]
12. Widespread and efficient transduction of spinal cord and brain following neonatal AAV injection and potential disease modifying effect in ALS mice.
Ayers JI; Fromholt S; Sinyavskaya O; Siemienski Z; Rosario AM; Li A; Crosby KW; Cruz PE; DiNunno NM; Janus C; Ceballos-Diaz C; Borchelt DR; Golde TE; Chakrabarty P; Levites Y
Mol Ther; 2015 Jan; 23(1):53-62. PubMed ID: 25228069
[TBL] [Abstract][Full Text] [Related]
13. Recombinant AAV-mediated VEGF gene therapy induces mandibular condylar growth.
Rabie AB; Dai J; Xu R
Gene Ther; 2007 Jun; 14(12):972-80. PubMed ID: 17460722
[TBL] [Abstract][Full Text] [Related]
14. Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors.
Raake PW; Hinkel R; Müller S; Delker S; Kreuzpointner R; Kupatt C; Katus HA; Kleinschmidt JA; Boekstegers P; Müller OJ
Gene Ther; 2008 Jan; 15(1):12-7. PubMed ID: 17943147
[TBL] [Abstract][Full Text] [Related]
15. AAV-PHP.B Administration Results in a Differential Pattern of CNS Biodistribution in Non-human Primates Compared with Mice.
Liguore WA; Domire JS; Button D; Wang Y; Dufour BD; Srinivasan S; McBride JL
Mol Ther; 2019 Nov; 27(11):2018-2037. PubMed ID: 31420242
[TBL] [Abstract][Full Text] [Related]
16. Intravenous administration of self-complementary AAV9 enables transgene delivery to adult motor neurons.
Duque S; Joussemet B; Riviere C; Marais T; Dubreil L; Douar AM; Fyfe J; Moullier P; Colle MA; Barkats M
Mol Ther; 2009 Jul; 17(7):1187-96. PubMed ID: 19367261
[TBL] [Abstract][Full Text] [Related]
17. Global gene transfer into the CNS across the BBB after neonatal systemic delivery of single-stranded AAV vectors.
Miyake N; Miyake K; Yamamoto M; Hirai Y; Shimada T
Brain Res; 2011 May; 1389():19-26. PubMed ID: 21397590
[TBL] [Abstract][Full Text] [Related]
18. Comparison of high-dose intracisterna magna and lumbar puncture intrathecal delivery of AAV9 in mice to treat neuropathies.
Bailey RM; Rozenberg A; Gray SJ
Brain Res; 2020 Jul; 1739():146832. PubMed ID: 32289279
[TBL] [Abstract][Full Text] [Related]
19. Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates.
Gray SJ; Nagabhushan Kalburgi S; McCown TJ; Jude Samulski R
Gene Ther; 2013 Apr; 20(4):450-9. PubMed ID: 23303281
[TBL] [Abstract][Full Text] [Related]
20. Pre-existing immunity to adeno-associated virus (AAV)2 limits transgene expression following intracerebral AAV2-based gene delivery in a 6-hydroxydopamine model of Parkinson's disease.
Janelidze S; Nordström U; Kügler S; Brundin P
J Gene Med; 2014; 16(9-10):300-8. PubMed ID: 25303717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
